Day: June 29, 2022

TORONTO, June 29, 2022 (GLOBE NEWSWIRE) — Consolidated Uranium Inc. (“CUR”, the “Company”, “Consolidated Uranium”) (TSXV: CUR) (OTCQB: CURUF) is pleased to provide the voting results from its annual general and special meeting of shareholders held virtually today. Each of the director nominees, being Philip Williams, Anthony Milewski, Mark Raguz, John Jentz and Mark Chalmers, was re-elected as a director of the Company to serve until the next annual general meeting of shareholders, or until his successor is otherwise elected or appointed. In addition, all other matters presented for approval at the meeting were duly authorized and approved, including:Appointment of McGovern Hurley LLP, Chartered Professional Accountants as auditors of the Company; and Approval of the Company’s amended and restated Omnibus Long Term Incentive...

Phoenix, AZ, June 29, 2022 (GLOBE NEWSWIRE) — InnSuites Hospitality Trust (NYSE American: IHT) On June 29, 2022, the Board of Trustees of IHT announced a semi-annual dividend of $0.01 per share, payable on July 29, 2022 to shareholders of record as of July 15, 2022. This announcement continues an uninterrupted 52-year history of annual dividends. InnSuites hotel operations continue to rebound strongly, while the investment in UniGen’s diversified efficient clean energy innovation continues to progress. IHT hotel operations are maintaining their solid start in the current 2023 Fiscal Year (February 1, 2022, to January 31, 2023), First and early Second Quarter, with both the Tucson Hotel and Albuquerque Hotel achieving record results for the current Fiscal Year to date (February 1, 2022, through June 29, 2022). Revenues for the Fiscal...

105 million 30 µg, 10 µg and 3 µg doses to be delivered into Q4 2022, with an option for the U.S. Government to purchase up to 195 million additional dosesNEW YORK and MAINZ, GERMANY, JUNE 29, 2022 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new vaccine supply agreement with the U.S. government to support the continued fight against COVID-19. Under the agreement, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg). This may include adult Omicron-adapted COVID-19 vaccines, subject to authorization from the U.S. Food and Drug Administration (FDA). The doses are planned to be delivered as soon as late summer 2022 and continue into the fourth quarter of this year. The U.S. government will pay the companies $3.2 billion upon receipt of the first 105 million doses. Under this agreement,...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. VANCOUVER, British Columbia, June 29, 2022 (GLOBE NEWSWIRE) — X1 Esports & Entertainment (CSE: XONE) (“X1” or the “Company”), a games & media portfolio company is pleased to announce that its shares will begin trading on June 30, 2022 on the Canadian Securities Exchange (the “Exchange”). X1 will trade under the stock ticker symbol “XONE”. “We could not be more proud of our organization in reaching this milestone of listing on the Canadian Securities Exchange,” said X1 Chief Executive Officer Mark Elfenbein. “In addition to our existing assets, there is a great opportunity to acquire companies within the games and creator economy markets...

– Closing of arrangement subject to regulatory approvals, including conditional listing approval by the TSX Venture Exchange.– Closing of the arrangement expected to occur in August.– Also announces closing of subscription receipt offering. TORONTO, June 29, 2022 (GLOBE NEWSWIRE) — Field Trip Health Ltd. (TSX: FTRP, FTRP.WT, Nasdaq: FTRP) (“Field Trip” or the “Corporation”), a global leader in the development and delivery of psychedelic therapies, today announces that on June 29, 2022, it received final court approval in respect of the previously announced spin-out of its clinics business to Field Trip Health & Wellness Ltd. (“Field Trip H&W”) by way of plan of arrangement (the “Arrangement”). Closing of the Arrangement remains subject to regulatory approvals, including...

SOUTH SAN FRANCISCO, Calif., June 29, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (“Cytokinetics”) (Nasdaq: CYTK) today announced its intention to offer, subject to market and other conditions, $450.0 million aggregate principal amount of convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Cytokinetics also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $90.0 million aggregate principal amount of notes. The notes will be senior, unsecured obligations of Cytokinetics and will accrue interest payable semi-annually in arrears. The notes...